Vis enkel innførsel

dc.contributor.authorLøvås, Kristianen_US
dc.contributor.authorCurran, Suzanneen_US
dc.contributor.authorØksnes, Marianneen_US
dc.contributor.authorHusebye, Eystein Sverreen_US
dc.contributor.authorHuppert, Felicia A.en_US
dc.contributor.authorChatterjee, V. Krishna K.en_US
dc.date.accessioned2014-08-21T13:32:43Z
dc.date.available2014-08-21T13:32:43Z
dc.date.issued2010-02eng
dc.identifier.issn1945-7197
dc.identifier.issn0021-972X
dc.identifier.urihttps://hdl.handle.net/1956/8312
dc.description.abstractContext: Patients with Addison’s disease reproducibly self-report impairment in specific dimensions of general well-being questionnaires, suggesting particular deficiencies in health-related quality-of-life (HRQoL). Objective:Wesought to develop an Addison’s disease-specific questionnaire (AddiQoL) that could better quantify altered well-being and treatment effects. Design, Setting, Patients, Intervention, and Outcomes: We reviewed the literature to identify HRQoL issues in Addison’s disease and interviewed patients and their partners in-depth to explore various symptom domains. A list of items was generated, and nine expert clinicians and five expert patients assessed the list for impact and clarity. A preliminary questionnaire was presented to 100 Addison’s outpatients; the number of items was reduced after analysis of the distribution of the responses. The final questionnaire responses were assessed by Cronbach’s and Rasch analysis. Results and Interpretation: Published studies of HRQoL in Addison’s disease indicated reduced vitality and general health perception and limitations in physical and emotional functioning. In-depth interviews of 14 patients and seven partners emphasized the impact of the disease on the emotional domain. Seventy HRQoL items were generated; after the expert consultation process and pretesting in 100 patients, the number of items was reduced to 36. Eighty-six patients completed the final questionnaire; the responses showed high internal consistency with Cronbach’s 0.95 and Person Separation Index 0.94 (Rasch analysis). Conclusions: We envisage AddiQoL having utility in trials of hormone replacement and management of patients with Addison’s disease, analogous to similar questionnaires in GH deficiency (AGHDA) and acromegaly (AcroQoL).en_US
dc.language.isoengeng
dc.publisherEndocrine Societyeng
dc.relation.ispartof<a href="http://hdl.handle.net/1956/8326" target="blank">Glucocorticoid Treatment and Quality of Life in Addison’s disease</a>eng
dc.titleDevelopment of a Disease-Specific Quality of Life Questionnaire in Addison’s Diseaseen_US
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2010 by The Endocrine Society
dc.identifier.doihttps://doi.org/10.1210/jc.2009-1711
dc.identifier.cristin339396
dc.source.journalJournal of Clinical Endocrinology and Metabolism
dc.source.4095
dc.source.142
dc.source.pagenumber545-551


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel